Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global microcurrent device market is expected to register a rapid revenue CAGR of 7% during the forecast period. The increasing demand for non-invasive ...
The eBalance® device is extraordinary for its ability to harness frequency-specific microcurrent to stimulate cellular function, promoting ATP production-the energy currency of cells. This ...
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / February 25, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する